Señales en vivo de BIAF | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 11.11% compare to its pairs and should correct upwards.

Stats
Volumen de hoy	71 934
Volumen promedio	137 936
Capitalización de mercado	23.32M
EPS	$-0.200 ( Q1 \| 2024-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.15 (Sector) 42.63 (Industry) 39.71
ATR14	$0.0110 (0.55%)

AWH 2.51%

BIAF -3.38%

BIAFW 3.51%

INBS -4.63%

LMDXW 0.00%

PRE -0.83%

PRENW 0.93%

Insider Trading

Date	Person	Action	Amount	type
2024-06-12	Rubin Gary D	Buy	8 296	Common Stock
2024-06-12	Diamond Stuart	Buy	8 296	Common Stock
2024-06-12	Girgenti Steven	Buy	8 296	Common Stock
2024-06-12	Zannes Maria	Buy	8 296	Common Stock
2024-06-12	Joyce Roby	Buy	8 296	Common Stock

INSIDER POWER
33.25
Last 96 transactions
Buy: 1 398 712 \| Sell: 1 311 919

Correlación (AI algo v.1.1b): Undervalued: 11.11% $2.22 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.15 (neutral)

Corto: -0.21 (neutral)

Signal:(43.17) Neutral

bioAffinity Technologies, Correlación

10 Correlaciones Más Positivas
CCSB	0.871
GECCI	0.867
AILEW	0.841
JVSAR	0.838

10 Correlaciones Más Negativas
OZEM	-1
PLFLX	-0.84
PLFDX	-0.838
PGLOX	-0.816
PLFRX	-0.815

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

bioAffinity Technologies, Correlación - Moneda/Commodity

-0.16
( neutral )

-0.32
( neutral )

0.00
( neutral )

-0.23
( neutral )

0.00
( neutral )

0.13
( neutral )

bioAffinity Technologies, Finanzas

Annual	2023
Ingresos:	$2.53M
Beneficio Bruto:	$542 023 (21.40 %)
EPS:	$-0.910

FY	2023
Ingresos:	$2.53M
Beneficio Bruto:	$542 023 (21.40 %)
EPS:	$-0.910

FY	2022
Ingresos:	$4 803.00
Beneficio Bruto:	$4 336.00 (90.28 %)
EPS:	$-1.810

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.32

Financial Reports:

No articles found.

bioAffinity Technologies, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

bioAffinity Technologies,

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.